Menu Menu


/ News
Thursday, 2nd December 2021 | 8,708 veterinary jobs online | 43 people actively seeking work | 5,161 practices registered

Veterinary Industry News

Send us your news

Carus Animal Health And SpheriTech Sign Licence Agreement To Develop Veterinary Applications For SpheriSome® Technology

9 months ago

17th February, 2021 12h36

Carus Animal Health

Carus Animal Health has entered into a commercial arrangement with independent research, development and manufacturing company SpheriTech. The two parties have agreed a worldwide exclusive licence for Carus to use SpheriTech’s patented SpheriSome® technology to make, develop and sell products for topical use in a range of veterinary applications.

SpheriTech, founded in 2009 by Don Wellings with a world-class scientific advisory board, focuses on research and development of novel and innovative materials for use in a wide range of industry sectors including healthcare, medical, biotechnology for use in humans and animals. The company has developed a number of patented technologies, including the licensed SpheriSome® technology which, with closely controlled particle size, biodegradability and anti-microbial properties, has wide-ranging uses as a delivery mechanism in many industry sectors.

SpheriSomes® are novel, multi-lamellar microparticles which consist entirely of naturally occurring fatty acids and an organic base. They can be polymerised into a 3D matrix or used as microparticle suspension. The first formulations to be developed will be based on poly-Ɛ-lysine, an antimicrobial peptide discovered in Japan in the 1980s. The resulting SpheriSomes® are innately antimicrobial and disrupt biofilms.

Jolian Howell, Chief Commercial Officer at Carus Animal Health, said: “There is great potential for SpheriSome® technology in animal healthcare, especially as the sector reduces its reliance on antibiotics. SpheriSomes® are just the sort of cutting edge, innovative technology we were established by our parent company, Kyoritsu Seiyaku Corporation, to focus on and develop.”

Don Wellings of SpheriTech Limited, said: “We’re delighted to have reached this agreement with Carus Animal Health and look forward to seeing our technology applied to develop new veterinary solutions. The agreement with Carus provides a terrific opportunity for commercialisation of the SpheriSome® technology and reflects our strategic plan of licensing the technology into a wide spectrum of application areas in human and animal healthcare, antimicrobial applications and as an alternative to microplastics. 

More from Carus Animal Health